10.17.25 -- End-To-End Biologics Solutions: From Development To Delivery

Join 1,000+ pharma, biotech, and drug delivery professionals at the PODD: Partnership Opportunities in Drug Delivery Conference conference, October 27–28 in Boston. Featuring 10 technology tracks, pharma company spotlights, 1:1 partnering, and more. Attendees will also hear from leaders at companies including AbbVie, Amgen, AstraZeneca, Biogen, Eli Lilly, GSK, Moderna, Novartis, Pfizer, Regeneron, Roche, Sanofi, Takeda, and others. Register at PODDConference.com with code LSL20 for 20% off.

With tox material in hand as soon as possible, antibody-derived drug developers can conduct their tox studies earlier, facilitating a timely IND submission and speeding up pathways to patients.

Our mission is to accelerate the development and manufacturing of our client‘s therapeutic and prophylactic products to treat serious diseases, that impact human health worldwide.

Detra Glinatsis, Vice President of Business Development, presents the advanced capabilities, strategic growth, and expanding capacity of Northway Biotech, a global biologics CDMO.

The SUREtechnology Platform™ is designed to overcome common expression bottlenecks, streamlining the development process from transfection to a fully characterized research cell bank (RCB).

Explore end-to-end services offered by a trusted CDMO partner with more than 15 years of industry-leading experience in conjugation and purpose-built manufacturing facilities.

Go on a virtual tour of our GMP-certified facility, where we uphold our expanded capabilities for large molecule development to the highest standards for clinical and commercial manufacturing.

Administering high doses of biologics subcutaneously offers numerous benefits, including reduced treatment burden, improved patient convenience, and increased adherence to regimens.

The kojoX philosophy is designed to overcome capacity constraints, regulatory complexities, and geopolitical risks to deliver unmatched scale, speed, supply chain agility, and resilience.

By combining technical excellence with a passion for progress, we enable our customers to bring life-changing therapies to market efficiently and reliably.

The 362 Master series two-side labeler offers a wide range of equipment options with various print and label presence checks in combination with bad label return and product rejection.